FDA Approved: NEXIUM — Supplemental Application (AstraZeneca Pharmaceuticals LP)

View source ↗

Summary

The FDA approved a supplemental application for Nexium (esomeprazole magnesium) submitted by AstraZeneca Pharmaceuticals LP to update the labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Erosive Esophagitis
• Gastric Ulcer
• Gastroesophageal Reflux Disease
• Helicobacter Pylori Infection
• Nsaid-associated Gastric Ulcer
• Zollinger-ellison Syndrome

Drugs mentioned

• Nexium (esomeprazole)

Snippet

SUPPL AP for NEXIUM (ESOMEPRAZOLE MAGNESIUM)